Cargando…
Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
Autores principales: | Herling, Marco, Jarjour, Wael, Mishra, Anjali, Brammer, Jonathan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490408/ https://www.ncbi.nlm.nih.gov/pubmed/36158669 http://dx.doi.org/10.3389/fonc.2022.991527 |
Ejemplares similares
-
Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease
por: Couette, Nina, et al.
Publicado: (2022) -
Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia
por: Isabelle, Colleen, et al.
Publicado: (2022) -
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
por: Braunstein, Zachary, et al.
Publicado: (2022) -
The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
por: Iyer, Sunil Girish, et al.
Publicado: (2023) -
Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Braun, Till, et al.
Publicado: (2021)